The primary diagnosis and the coexisting anxiety disorders have no impact on the additional surgical procedure after spinal cord stimulators implantation: An analysis of 11,029 patients.
Studies have demonstrated superior outcomes and cost effectiveness of the spinal cord stimulation (SCS) for the treatment of chronic pain syndromes such as failed back surgery syndrome (FBSS) or complex regional pain syndrome (CRPS). However, little is known about the impact of primary diagnosis or mental disorders on the revision rate. This is the Retrospective cohort study to analyze the reintervention rates based on the primary diagnosis or comorbid mental disorder. Data of the annual trends of SCS use, revision and removal rate of SCS and additional surgical rate after removal was collected and analyzed for patients undergoing SCS between 2007 and 2015, within a private insurance billing database. Trial cases were excluded from this study. The results showed 11,029 patients received SCS implantation with percutaneous electrodes (PE, n = 7418) or surgical electrode (SE, n = 3611). There was a trend of increasing use of SCS from 2007 to 2013, followed by a decrease in last two years. There was no significant difference in the neither removal nor revision rate regardless between the patients with FBSS or CRPS at each time point. Although the removal rates within 2 years were significantly higher in the patients with anxiety disorders compared to the patients without any mental disorders (PE: p < .001, SE: 0.003), the rate of additional surgery after the removal showed no significant difference (PE: p = .532, SE: p = .262). Therefore, we concluded that the primary diagnosis and the presence of anxiety disorders did not have an impact on the additional surgical rate following SCS implantation.